Commentary: braf v600 mutation and braf kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study

Rimas V. Lukas

doi:10.1093/neuros/nyy241

Commentary: braf v600 mutation and braf kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study

Rimas V. Lukas^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	881-882
Number of pages	2
Journal	Clinical Neurosurgery
Volume	84
Issue number	4
DOIs	https://doi.org/10.1093/neuros/nyy241
State	Published - Apr 1 2019

ASJC Scopus subject areas

Clinical Neurology
Surgery

Access to Document

10.1093/neuros/nyy241

Cite this

@article{2cd4c5582f25474ea31d79f5dfbd26ea,

title = "Commentary: braf v600 mutation and braf kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study",

author = "Lukas, {Rimas V.}",

year = "2019",

month = apr,

day = "1",

doi = "10.1093/neuros/nyy241",

language = "English (US)",

volume = "84",

pages = "881--882",

journal = "Clinical Neurosurgery",

issn = "0148-396X",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Commentary

T2 - braf v600 mutation and braf kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study

AU - Lukas, Rimas V.

PY - 2019/4/1

Y1 - 2019/4/1

UR - http://www.scopus.com/inward/record.url?scp=85062965904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062965904&partnerID=8YFLogxK

U2 - 10.1093/neuros/nyy241

DO - 10.1093/neuros/nyy241

M3 - Comment/debate

C2 - 29846721

AN - SCOPUS:85062965904

SN - 0148-396X

VL - 84

SP - 881

EP - 882

JO - Clinical Neurosurgery

JF - Clinical Neurosurgery

IS - 4

ER -

Commentary: braf v600 mutation and braf kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this